Logo

neurodegenerative disease

Engine Biosciences Using CRISPR, Machine Learning to Build Drug Candidate Pipeline
Premium

Fresh off a $43 million fundraising round, the drug discovery-focused bioinformatics firm is validating novel drug targets and compounds with an eye toward 2023 clinical trials.

Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays

The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.

Alzheimer's Disease Genomes Lead to Novel Loci Involved in Synaptic Function

Starting with genome sequences for thousands of individuals from Alzheimer's-affected families, researchers found rare disease-associated variants at 13 new loci.

Neanderthal Gene Variant Alters Neurodevelopment in Human Brain Organoids

Researchers used CRISPR to reintroduce an archaic variant of NOVA1 into cortical organoids to study how a human-specific variant may have affected evolution.

Alzheimer's Disease Subtypes Proposed From Gene Expression Profiles of Brain Regions

Investigators identified five expression subtypes spanning three broader clusters in postmortem parahippocampal gyrus samples from Alzheimer's patients.

Jan 7, 2021

Genuity Science, Emory Team on Biomarker Discovery for Neurodegenesis

Nov 9, 2020

Invitae, Passage Bio Collaborate on GM1 Genetic Testing, Clinical Trial Education

May 21, 2020

PrecisionLife Pivots to In Silico Target Validation, COVID-19 Drug Repurposing
Premium

Jun 26, 2019

Quanterix to Acquire UmanDiagnostics for $22.5M

Dec 5, 2018

Chan Zuckerberg Initiative Awards $52M in Grants for Neurodegenerative Disease Research

Jul 16, 2018

Verge Genomics Scores $32M in Series A Round

May 24, 2018

Cancer Increase Reported in Families With Tau Mutation-Associated Neurodegeneration

Apr 9, 2018

Sporadic ALS Risk Appears to Overlap Slightly With Other Neurodegenerative Conditions

Feb 9, 2018

Q-State Subsidiary Buys Claritas Assets, Plans Relaunch of Lab to Support Drug Discovery Programs
Premium

Jan 10, 2018

Crohn's, Parkinson's Diseases Share Risk Gene

Dec 13, 2017

Berg, MGH, BWH, Collaborate on Neurodegenerative Disorder Biomarker Identification, Treatment

Dec 7, 2017

New Giro Health Open Initiative Seeks Answers to Neurodegenerative Diseases

Sep 28, 2016

Quanterix Invests in ImmunArray, Gains Access to Brain Injury Biomarker Portfolio

May 23, 2016

Aurum Ventures Invests $1.2M in Hebrew U's Yissum for Circulating DNA Test Development

Feb 3, 2016

Cofactor Genomics Acquires Narus Biotechnologies

Jan 11, 2016

Diamir Inks Evaluation Deal with Janssen for microRNA Dx Technology

Nov 5, 2015

Affymetrix, XRGenomics Collaborate on Dx for Age-Related Diseases

Oct 28, 2015

Verge Genomics Raises $4M in Seed Financing

Jun 25, 2015

Amprion Wins NIH Grant to Develop Alzheimer's Disease Diagnostic
Premium

Jan 13, 2015

Amarantus Acquires DioGenix for up to $10.9M

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.